NGF/BDNF-Trk/p75NTR signaling in osteosarcoma immunity: biomarkers and therapeutic opportunities. [PDF]
Front ImmunolAn L, Zhuang Y, Sun H.
europepmc +1 more source
Successful treatment of pediatric scalp mesenchymal tumor with NTRK rearrangement: a case report. [PDF]
Transl PediatrMa F +5 more
europepmc +1 more source
Tropomyosin 3 Gene Fusions in Cancers: From Mechanisms to Treatments-A Comprehensive Review. [PDF]
Cancer MedChen A +7 more
europepmc +1 more source
TPM3-NTRK1 Fusion Cervical Sarcoma: A Case Report of a Novel Subset of Gynaecological Sarcomas and Successful Treatment of Recurrent Disease With Trk-Inhibition Therapy. [PDF]
CureusLowe-Zinola J +4 more
europepmc +1 more source
Extraskeletal osteosarcoma harboring ETV6::NTRK3 fusion treated successfully with larotrectinib: a case study. [PDF]
Commun Med (Lond)Skok K +8 more
europepmc +1 more source
Efficacy of larotrectinib in pediatric cancers with <i>NTRK</i> gene fusions. [PDF]
Transl PediatrHoughton PJ, Bjornsti MA.
europepmc +1 more source
Neurotrophic factors as double-edged swords in osteosarcoma: drivers of tumour growth and immune remodelling. [PDF]
Front ImmunolLei P, Li L.
europepmc +1 more source
Dramatic response to entrectinib in a rare glioneuronal tumor harboring an NTRK2 fusion. [PDF]
OncologistAkrout F +5 more
europepmc +1 more source
Trk Signaling Inhibition Reduces cSCC Growth and Invasion in In Vitro and Zebrafish Models and Enhances Photodynamic Therapy Outcome. [PDF]
Int J Mol SciQuadri M +7 more
europepmc +1 more source